Cerus Corporation Announces Workshop and Abstracts at the 20

Workshop and Presentations Highlight the Benefits of Real-world Utilization of INTERCEPT-treated Blood Products, including the INTERCEPT Blood System for Platelets and INTERCEPT Fibrinogen Complex

...

Related Keywords

Stanford University , California , United States , France , , Cerus Corporation Nasdaq , Linkedin , University Of Texas Southwestern Medical Center , Pediatric Level Ii Trauma Center , Cerus Corporation , Blood Bank Product Preparation Time , Central Daylight Time , Pathogen Reduced Cryoprecipitate , Early Experiences , Inventory Management Outcomes , Texas Southwestern Medical Center , Cerus Industry Workshop , Pathogen Reduced Cold Stored Platelets , Pathogen Reduction , Improved Blood Safety , American Red Cross , Establissement Francais , Reduced Platelet Components Transfused , Premature Neonates , Pediatric Level , Operational Efficiency , Assess Red Blood Cell Clearance , Vivo Utilizing Pathogen Reduced , Markets ,